Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: A study on delivery efficiency

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 11, 2012, Pages 2768-2776

  Van der Spoel, Tycho I G ^a   Vrijsen, Krijn R ^a   Koudstaal, Stefan ^a   Sluijter, Joost P G ^a,b   Nijsen, Johannes Frank W ^a   de Jong, Hugo W ^a   Hoefer, Imo E ^a   Cramer, Maarten Jan M ^a   Doevendans, Pieter A ^a,b   van Belle, Eric ^a   Chamuleau, Steven A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Catheters; Chronic ischaemia; Nuclear medicine; Stem cells

Indexed keywords

ANIMAL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; FEMALE; HEART MUSCLE ISCHEMIA; INFUSION; INJECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; PHYSIOLOGY; RANDOMIZATION; SWINE;

ANIMALS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; FEMALE; INFUSIONS, PARENTERAL; INJECTIONS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL ISCHEMIA; RANDOM ALLOCATION; SUS SCROFA;

ANIMALIA; SUIDAE; SUS;

EID: 84868135415     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01594.x     Document Type: Article

References (30)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the american heart association statistics committee and stroke statistics subcommittee. Circulation. 2008; 117: e25-146.
2. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007; 167: 989-97.
3. van der Spoel TIG, Jansen of Lorkeers S, Agostoni P, et al. Human relevance of pre-clinical studies in stem cell therapy; systematic review and meta-analysis of large animal models of ischemic heart disease. Cardiovasc Res. 2011; 91: 649-58.
4. Bartunek J, Dimmeler S, Drexler H, et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J. 2006; 27: 1338-40.
5. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006; 355: 1222-32.
6. Katritsis DG, Sotiropoulou PA, Karvouni E. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv. 2005; 65: 321-9.
7. Tse HF, Thambar S, Kwong YL, et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J. 2007; 28: 2998-3005.
8. van Ramshorst J, Bax JJ, Beeres SLMA, et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA. 2009; 301: 1997-2004.
9. Timmers L, Henriques JPS, de Kleijn DPV, et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009; 53: 501-10.
10. Noort WA, Oerlemans MIFJ, Rozemuller H, et al. Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med. 2011; doi:10.1111/j.1582-4934.2011.01455.x.
11. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996; 93: 879-88.
12. Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 1996; 2: 1393-5.
13. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation. 1997; 95: 1611-22.
14. Baan J, van der Velde ET, de Bruin HG, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 1984; 70: 812-23.
15. Steendijk P, Baan J. Comparison of intravenous and pulmonary artery injections of hypertonic saline for the assessment of conductance catheter parallel conductance. Cardiovasc Res. 2000; 46: 82-9.
16. Steendijk P, Baan J Jr, Van Der Velde ET, et al. Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart. J Am Coll Cardiol. 1998; 32: 816-26.
17. Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006; 27: 1114-22.
18. Gyongyosi M, Hemetsberger R, Wolbank S, et al. Imaging the migration of therapeutically delivered cardiac stem cells. JACC: Cardiovasc Imaging. 2010; 3: 772-5.
19. Hou D, Youssef EA-S, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 2005; 112: I-150.
20. Perin EC, Silva GV, Assad JA, et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008; 44: 486-95.
21. Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007; 110: 1362-9.
22. Lyngbaek S, Ripa R, Haack-Sorensen M, et al. Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells. Int J Cardiovas Imaging. 2010; 26: 273-84.
23. Huang XP, Sun Z, Miyagi Y, et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation. 2010; 122: 2419-29.
24. Kornowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation. 1998; 98: 1116-24.
25. Li Q, Guo Y, Ou Q, et al. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011; 106: 849-64.
26. Dib N, Dinsmore J, Lababidi Z, et al. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC Study). J Am Col Cardiol Intv. 2009; 2: 9-16.
27. Mansour S, Vanderheyden M, De Bruyne B, et al. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol. 2006; 47: 1727-30.
28. Gyongyosi M, Lang I, Dettke M, et al. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med. 2009; 6: 70-81.
29. Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. The Lancet. 2004; 363: 783-4.
30. Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 2005; 112: 1451-61.